| ［1］ Tansey W,Hunter N，Buchmiller L. Tumor irradiation enhances the tumorspecific distribution of poly (L-glutamic acid)conjugation paclitaxel and its antitumor efficacy. Clinical Cancer Research, 2000, 6(7): 2829~2834 ［2］ Singer J W,Vries D E, Bhatt R, et al. Conjugation of camptothecins to Poly(L-glutamic acid). Annals of the NewYork Academy of Science, 2000, 922: 136~150 ［3］ Li C K, Wn Q P. Tumor irradiation enhances the tumorspecific distribution of poly(Lglutamic acid)conjugation paclitaxel and its antitumor efficacy. Clinical Cancer Research, 2000, 6(7): 2829~2834 ［4］ Oldham E A, Li C, Ke S, et al. Comparison of action of paclitaxel and poly (Lglutamic acid) paclitaxel conjugate in human breast cancer cells. International Journal of Oncology, 2000, 16(l): 125~132 ［5］ Atsuo G, Masao K. Biosynthesis and hydrolysis of poly(γglutamic acid from Bacillus subtilis IF03335. Bioteeh Bioehem, 1992, 56(7): 1031~1035 ［6］ Bhatt R,De Vriesp P. Poly glutamic acidcamptothecin conjugates and methods of Preparation. US.PatentUS2002/016285 AI ［7］ Avichezer D,Amon R. Functional polymers in drug delivery: cariersupport CDDP(cisplatin) complexs of polycarboxylateseffect on human ovarian carcinoma．React Funct Polym, 1998, 36(I): 59~69 ［8］ Cao X H,Ha Z R,Wang C L, et al. Optimizing fermentation conditions of poly (γglutamic acid) by Bacillus natto TK2. Food and Fermentation Industry, 2008, 34(I): 24~27 ［9］ Maeda H, Seymour L W, Miyamoto Y. Conjugates of anticancer agents and polymers: advantages of macromolecular the rapeutics in vivo. Biocon jugate chem, 1992, 3: 351~362 ［10］杨革，陈坚，曲音波，等。聚γ谷氨酸表征的研究.高分子材料科学与工程，2002, 18 (4): 133~136 Yang G, Chen J, Qu Y B, et al.Polymer Science and Engineering, 2002,18(4):133~136 ［11］ Nakano M M, Magusson R, Myers A, et al. SrfA is an operon required for surfactin production, competence development and efficient sporulation in Bacillus subtilis. J Bacteriol, 1991, 173: 70~78 ［12］ Ye H F. Preparation and biological activity of poly (γglutamic acid)cisplatin conjugate.Acta Pharmaceutica Sinica, 2007, 42(6): 611~617 ［13］ Rao M V. Solution conformation of poly (LlysylLglutamic acid) and poly (LlysylLglutamine). Protein Res, 1984, 24(1): 48~54 ［14］ Dai Y, Liu X J, Zhen Y S. Antitumor effect of the novel immune conjugate composed of pingyangmyc in and antitype IV collagenase monoclonal antibody. Acta Pharm Sin, 2006, 41: 41~46 ［15］ Richard A, Margaritis A. Poly ( glutamic acid) for biomedical applications. CritRev Biotechno, 2001, 21: 219~232 ［16］ Li C. Poly (Lglutamic acid)anticancer drug conjugates. Adv Drug Delivery Rev, 2002, 54: 695~713 ［17］ Prodhomme E J, Tutt A L, Glennie M J, et al. Multivalent conjugates of polygammaDglutamic acid from Bacillus licheniformis with antibody F ( ab') and glycopeptideligands. Bioconjugate Chem, 2003, 14: 1148 ~1155 |
